Search

everythinglearnresearchcommunity

for

Search:↓

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Erlotinib can cause acne-like skin issues, needing early treatment and possible dosage adjustments.

Finasteride can cause skin reactions, so dermatologists should be aware.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

A patient's skin eruption was caused by the cancer drug cyclophosphamide and improved after stopping the drug.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

A rare skin rash after COVID-19 vaccination shouldn't stop future vaccinations.

Restoring phenylalanine levels improved skin and hair symptoms in a PKU infant.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Finasteride can cause rare but serious skin rashes.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Erythematous papulopustular eruptions in cancer patients using EGFR inhibitors show specific skin changes that vary with severity and treatment type.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

A 68-year-old man improved after being correctly diagnosed and treated for a skin condition caused by mites, following a stem cell transplant.

A man developed a rare skin condition after a hair transplant surgery.

Minoxidil, a hair loss treatment, may cause acne-like skin eruptions.

A patient with pemphigus vulgaris improved significantly after treatment for an additional viral skin infection.

The combination therapy of PEG-IFN α-2a and Ribavirin can cause widespread hair loss and skin reactions.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

A rare skin reaction from laser hair removal can be prevented with medication.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Skin symptoms linked to COVID-19 are hard to confirm, and more testing is needed to identify which are truly caused by the virus.

Cetuximab can cause skin cysts after acne-like eruptions.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

Skin problems like rashes and hair loss can help diagnose and predict COVID-19.